Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
LivFul and Global Access Diagnostics announce partnership for COVID-19 test kit distribution 2021-06-09 10:00
Antengene's Partner Karyopharm Therapeutics Announces Updated Data of Eltanexor in Patients with Hypomethylating Agent Refractory MDS 2021-06-09 08:00
Sirtex Medical provides donations to Massachusetts Institute of Technology (MIT) and Brigham and Women's Hospital in support of the Artzi Lab, as part of Sirtex's corporate citizenship strategy to support research and innovation 2021-06-08 20:30
Innoforce Pharmaceuticals to Participate in BIO International Digital Convention 2021-06-08 19:00
Neoss Announces NeossONE™ - One Platform, Smart Prosthetics 2021-06-08 18:15
TargEDys announces the publication of the first double-blind, randomized, placebo-controlled clinical trial showing Hafnia alvei's efficacy at an unprecedented level in weight loss and satiety 2021-06-08 16:53
Inspiring Women's Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System 2021-06-08 15:37
Copan strengthens its operations in the Americas with a millionaire investment 2021-06-08 14:00
Onward Therapeutics Signs an Exclusive Collaboration and Worldwide Option and License Agreement with Institut du Cancer de Montpellier 2021-06-08 12:00
Cytiva opens experience and learning lab in Singapore 2021-06-08 10:00
Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress 2021-06-08 08:00
Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL 2021-06-08 07:30
Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs 2021-06-08 07:21
ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto Rico 2021-06-07 21:00
Elekta's new strategy to focus on growth and access to radiation therapy 2021-06-07 20:44
RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study 2021-06-07 19:00
Device Companies will Drive Surgery Automation to Increase Elective Procedures in Western Europe 2021-06-07 18:02
Elekta and Philips deepen strategic partnership in precise and individualized oncology care 2021-06-07 16:02
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Plus Paclitaxel/Cisplatin for the First-line Treatment of ESCC at ASCO 2021 2021-06-07 10:11
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Combined with Chemotherapy for the Treatment of Advanced NSCLC at ASCO 2021 2021-06-07 10:10
1 279 280 281 282 283 532